Julian Chandler M.Sc.

Company: Alexion, AstraZeneca Rare Disease

Job title: Associate Director

Seminars:

Discovery of a Novel Trifunctional Inhibitor for B Cell Driven Diseases 11:30 am

• Trifunctional target inhibition to address the root causes of B cell-driven diseases • Engineering best-in-class pH-dependent binding to FcRn for clearance of IgG and extended 1/2-lifeRead more

day: Conference Day Two